Uthorization Of Casirivimab And Imdevimab With English-only Labels For Use In Relation To The Covid-19 Pandemic
Recall Summary Health Canada has authorized the use of casirivimab and imdevimab, two monoclonal antibody drugs used to treat COVID-19, but only with English-language labels across Canada. This authorization applies to the drug supply distributed throughout the country.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-07-30
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/e75ec06a-96be-44c6-ab0f-7356f439fb11